Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

ART0380

Copy Product Info
😃Good
Catalog No. T85731Cas No. 2267316-76-5
Alias IACS-030380, IACS030380, ART 0380

ART0380 is a potent, selective, orally available, ATP-competitive ATR kinase inhibitor (IC50=51.7 nM) with antitumor activity for the study of ataxia telangiectasia mutated (ATM) cancer.

ART0380

ART0380

Copy Product Info
😃Good
Purity: 99.76%
Catalog No. T85731Alias IACS-030380, IACS030380, ART 0380Cas No. 2267316-76-5
ART0380 is a potent, selective, orally available, ATP-competitive ATR kinase inhibitor (IC50=51.7 nM) with antitumor activity for the study of ataxia telangiectasia mutated (ATM) cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$64-In Stock
5 mg$156In StockIn Stock
10 mg$222In StockIn Stock
25 mg$396-In Stock
50 mg$562-In Stock
100 mg$787-In Stock
200 mg$1,070-In Stock
1 mL x 10 mM (in DMSO)$169-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.76%
ee:100%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
ART0380 is a potent, selective, orally available, ATP-competitive ATR kinase inhibitor (IC50=51.7 nM) with antitumor activity for the study of ataxia telangiectasia mutated (ATM) cancer.
In vivo
ART0380 is a potent and selective ATR inhibitor with a compelling in vitro and in vivo pharmacological profile and is currently in Phase 2 clinical studies in patients with advanced or metastatic solid tumors as monotherapy and in combination with DNA damaging agents (NCT04657068 and NCT05798611). ART0380 has a favorable human PK profile suitable for both intermittent and continuous once-daily (QD) dosing, characterized by dose-proportional increases in exposure and low variability. [2]
SynonymsIACS-030380, IACS030380, ART 0380
Chemical Properties
Molecular Weight388.49
FormulaC18H24N6O2S
Cas No.2267316-76-5
SmilesC[C@H]1N(CCOC1)C2=NC(C3=CC=NC(N)=C3)=NC(N=S(C4CC4)(C)=O)=C2
Storage & Solubility Information
Storagestore at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy ART0380 | purchase ART0380 | ART0380 cost | order ART0380 | ART0380 chemical structure | ART0380 in vivo | ART0380 formula | ART0380 molecular weight